<!-- KEYWORD_LINKING_METADATA:
{
  "processed_timestamp": "2025-09-24T13:37:21.575112",
  "vocabulary_version": "1.0",
  "selected_keywords": [
    "Machine Learning",
    "Pathway Mapping",
    "Therapeutic Target Discovery",
    "Insulin Signaling Pathway",
    "Pima Indian Dataset"
  ],
  "rejected_keywords": [],
  "similarity_scores": {
    "Machine Learning": 0.85,
    "Pathway Mapping": 0.8,
    "Therapeutic Target Discovery": 0.75,
    "Insulin Signaling Pathway": 0.78,
    "Pima Indian Dataset": 0.7
  },
  "extraction_method": "AI_prompt_based",
  "budget_applied": true,
  "candidates_json": {
    "candidates": [
      {
        "surface": "Machine Learning",
        "canonical": "Machine Learning",
        "aliases": [
          "ML"
        ],
        "category": "broad_technical",
        "rationale": "Machine Learning is a foundational technique used in the framework, connecting it to broader technical discussions.",
        "novelty_score": 0.45,
        "connectivity_score": 0.9,
        "specificity_score": 0.5,
        "link_intent_score": 0.85
      },
      {
        "surface": "Pathway Mapping",
        "canonical": "Pathway Mapping",
        "aliases": [
          "Gene-Agnostic Pathway Mapping"
        ],
        "category": "unique_technical",
        "rationale": "Pathway Mapping is a novel approach in the study that bridges predictive analytics with biological relevance.",
        "novelty_score": 0.75,
        "connectivity_score": 0.7,
        "specificity_score": 0.8,
        "link_intent_score": 0.8
      },
      {
        "surface": "Therapeutic Target Discovery",
        "canonical": "Therapeutic Target Discovery",
        "aliases": [
          "Target Discovery"
        ],
        "category": "unique_technical",
        "rationale": "This is a key outcome of the framework, providing a unique angle on precision medicine.",
        "novelty_score": 0.7,
        "connectivity_score": 0.65,
        "specificity_score": 0.78,
        "link_intent_score": 0.75
      },
      {
        "surface": "Insulin Signaling Pathway",
        "canonical": "Insulin Signaling Pathway",
        "aliases": [
          "Insulin Pathway"
        ],
        "category": "specific_connectable",
        "rationale": "The Insulin Signaling Pathway is critical to the study's focus on metabolic disorders, offering specific biological insights.",
        "novelty_score": 0.55,
        "connectivity_score": 0.8,
        "specificity_score": 0.85,
        "link_intent_score": 0.78
      },
      {
        "surface": "Pima Indian Dataset",
        "canonical": "Pima Indian Dataset",
        "aliases": [
          "Pima Dataset"
        ],
        "category": "unique_technical",
        "rationale": "This dataset is central to the study's analysis, providing a unique context for the research.",
        "novelty_score": 0.8,
        "connectivity_score": 0.6,
        "specificity_score": 0.9,
        "link_intent_score": 0.7
      }
    ],
    "ban_list_suggestions": [
      "Metabolic Disorders",
      "Type 2 Diabetes Mellitus"
    ]
  },
  "decisions": [
    {
      "candidate_surface": "Machine Learning",
      "resolved_canonical": "Machine Learning",
      "decision": "linked",
      "scores": {
        "novelty": 0.45,
        "connectivity": 0.9,
        "specificity": 0.5,
        "link_intent": 0.85
      }
    },
    {
      "candidate_surface": "Pathway Mapping",
      "resolved_canonical": "Pathway Mapping",
      "decision": "linked",
      "scores": {
        "novelty": 0.75,
        "connectivity": 0.7,
        "specificity": 0.8,
        "link_intent": 0.8
      }
    },
    {
      "candidate_surface": "Therapeutic Target Discovery",
      "resolved_canonical": "Therapeutic Target Discovery",
      "decision": "linked",
      "scores": {
        "novelty": 0.7,
        "connectivity": 0.65,
        "specificity": 0.78,
        "link_intent": 0.75
      }
    },
    {
      "candidate_surface": "Insulin Signaling Pathway",
      "resolved_canonical": "Insulin Signaling Pathway",
      "decision": "linked",
      "scores": {
        "novelty": 0.55,
        "connectivity": 0.8,
        "specificity": 0.85,
        "link_intent": 0.78
      }
    },
    {
      "candidate_surface": "Pima Indian Dataset",
      "resolved_canonical": "Pima Indian Dataset",
      "decision": "linked",
      "scores": {
        "novelty": 0.8,
        "connectivity": 0.6,
        "specificity": 0.9,
        "link_intent": 0.7
      }
    }
  ]
}
-->

# A Machine Learning Framework for Pathway-Driven Therapeutic Target Discovery in Metabolic Disorders

## 📋 메타데이터

**Links**: [[daily_digest_20250924|20250924]] [[categories/cs.AI|cs.AI]]
**PDF**: [Download](https://arxiv.org/pdf/2509.18140.pdf)
**Category**: cs.AI
**Published**: 2025-09-24
**ArXiv ID**: [2509.18140](https://arxiv.org/abs/2509.18140)

## 🔗 유사한 논문
- [[2025-09-22/Temperature-Driven Robust Disease Detection in Brain and Gastrointestinal Disorders via Context-Aware Adaptive Knowledge Distillation_20250922|Temperature-Driven Robust Disease Detection in Brain and Gastrointestinal Disorders via Context-Aware Adaptive Knowledge Distillation]] (79.3% similar)
- [[2025-09-23/MRN_ Harnessing 2D Vision Foundation Models for Diagnosing Parkinson's Disease with Limited 3D MR Data_20250923|MRN: Harnessing 2D Vision Foundation Models for Diagnosing Parkinson's Disease with Limited 3D MR Data]] (79.3% similar)
- [[2025-09-24/Model selection meets clinical semantics_ Optimizing ICD-10-CM prediction via LLM-as-Judge evaluation, redundancy-aware sampling, and section-aware fine-tuning_20250924|Model selection meets clinical semantics: Optimizing ICD-10-CM prediction via LLM-as-Judge evaluation, redundancy-aware sampling, and section-aware fine-tuning]] (79.1% similar)
- [[2025-09-23/System-Level Uncertainty Quantification with Multiple Machine Learning Models_ A Theoretical Framework_20250923|System-Level Uncertainty Quantification with Multiple Machine Learning Models: A Theoretical Framework]] (79.0% similar)
- [[2025-09-23/Medical priority fusion_ achieving dual optimization of sensitivity and interpretability in nipt anomaly detection_20250923|Medical priority fusion: achieving dual optimization of sensitivity and interpretability in nipt anomaly detection]] (79.0% similar)

## 🏷️ 카테고리화된 키워드
**🧠 Broad Technical**: [[keywords/Machine Learning|Machine Learning]]
**🔗 Specific Connectable**: [[keywords/Insulin Signaling Pathway|Insulin Signaling Pathway]]
**⚡ Unique Technical**: [[keywords/Pathway Mapping|Pathway Mapping]], [[keywords/Therapeutic Target Discovery|Therapeutic Target Discovery]], [[keywords/Pima Indian Dataset|Pima Indian Dataset]]

## 📋 저자 정보

**Authors:** 

## 📄 Abstract (원문)

arXiv:2509.18140v1 Announce Type: cross 
Abstract: Metabolic disorders, particularly type 2 diabetes mellitus (T2DM), represent a significant global health burden, disproportionately impacting genetically predisposed populations such as the Pima Indians (a Native American tribe from south central Arizona). This study introduces a novel machine learning (ML) framework that integrates predictive modeling with gene-agnostic pathway mapping to identify high-risk individuals and uncover potential therapeutic targets. Using the Pima Indian dataset, logistic regression and t-tests were applied to identify key predictors of T2DM, yielding an overall model accuracy of 78.43%. To bridge predictive analytics with biological relevance, we developed a pathway mapping strategy that links identified predictors to critical signaling networks, including insulin signaling, AMPK, and PPAR pathways. This approach provides mechanistic insights without requiring direct molecular data. Building upon these connections, we propose therapeutic strategies such as dual GLP-1/GIP receptor agonists, AMPK activators, SIRT1 modulators, and phytochemical, further validated through pathway enrichment analyses. Overall, this framework advances precision medicine by offering interpretable and scalable solutions for early detection and targeted intervention in metabolic disorders. The key contributions of this work are: (1) development of an ML framework combining logistic regression and principal component analysis (PCA) for T2DM risk prediction; (2) introduction of a gene-agnostic pathway mapping approach to generate mechanistic insights; and (3) identification of novel therapeutic strategies tailored for high-risk populations.

## 📝 요약

이 연구는 Pima 인디언을 대상으로 한 데이터셋을 활용하여 제2형 당뇨병(T2DM) 고위험군을 식별하고 잠재적 치료 표적을 발견하기 위한 새로운 머신러닝(ML) 프레임워크를 제안합니다. 로지스틱 회귀와 t-검정을 통해 T2DM의 주요 예측 변수를 식별하여 78.43%의 모델 정확도를 달성했습니다. 예측 분석과 생물학적 관련성을 연결하기 위해 인슐린 신호, AMPK, PPAR 경로와 같은 중요한 신호 네트워크와 예측 변수를 연결하는 경로 매핑 전략을 개발했습니다. 이를 통해 분자 데이터 없이도 기전적 통찰을 제공합니다. 또한, GLP-1/GIP 수용체 작용제, AMPK 활성화제, SIRT1 조절제, 식물 화학물질과 같은 치료 전략을 제안하고 경로 강화 분석을 통해 이를 검증했습니다. 주요 기여는 (1) 로지스틱 회귀와 주성분 분석(PCA)을 결합한 T2DM 위험 예측 ML 프레임워크 개발, (2) 기전적 통찰을 제공하는 유전자 비특이적 경로 매핑 접근법 도입, (3) 고위험군에 맞춘 새로운 치료 전략 식별입니다.

## 🎯 주요 포인트

- 1. 이 연구는 유전자 비특이적 경로 매핑과 예측 모델링을 통합한 새로운 기계 학습 프레임워크를 제안하여 T2DM 고위험군을 식별하고 잠재적 치료 표적을 발견합니다.
- 2. Pima 인디언 데이터를 사용하여 로지스틱 회귀와 t-테스트를 통해 T2DM의 주요 예측 변수를 식별하고, 모델의 전체 정확도는 78.43%로 나타났습니다.
- 3. 예측 분석과 생물학적 관련성을 연결하기 위해 인슐린 신호, AMPK, PPAR 경로를 포함한 중요한 신호 네트워크와 예측 변수를 연결하는 경로 매핑 전략을 개발했습니다.
- 4. 이 연구는 GLP-1/GIP 수용체 작용제, AMPK 활성제, SIRT1 조절제 및 식물 화학 물질과 같은 치료 전략을 제안하고, 경로 강화 분석을 통해 이를 추가로 검증했습니다.
- 5. 이 프레임워크는 T2DM 위험 예측을 위한 로지스틱 회귀와 주성분 분석(PCA)을 결합한 ML 프레임워크 개발, 기계적 통찰을 생성하는 유전자 비특이적 경로 매핑 접근법 도입, 고위험군에 맞춘 새로운 치료 전략 식별을 주요 기여로 합니다.


---

*Generated on 2025-09-24 13:37:21*